AC-201

DRUG3 trials

Sponsors

TWi Biotechnology, Inc., Accro Bioscience (Suzhou) Limited

Conditions

GoutGout FlaresPlaque Psoriasis

Phase 2

A Proof-of-Concept Study of AC-201 to Prevent Gout Flares

CompletedNCT01712204

TWi Biotechnology, Inc.Gout Flares

Start: 2013-01-31End: 2013-09-30Updated: 2018-05-22

A Study of AC-201 Controlled-Release Tablet (CR Tablet) in Patients With Gout

CompletedNCT02287818

TWi Biotechnology, Inc.Gout

Start: 2014-12-31End: 2016-10-27Updated: 2022-06-28

A Phase II Clinical Study of AC-201 Tablets in Subjects With Plaque Psoriasis

CompletedNCT06972888

Accro Bioscience (Suzhou) LimitedPlaque Psoriasis

Start: 2024-04-23End: 2025-04-28Updated: 2025-05-22